Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin and Hydroxychloroquine in ICU Patients with COVID-19
NCT04339816Phase 3Terminated
- Start
- May 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine, azithromycin in coronavirus disease 2019 (COVID-19). Started May 2020; status: terminated.
02
Drugs
hydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04339816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04339816.